Profiling B cell immune responses to identify neutralizing antibodies from convalescent COVID-19 patients
Lisu Huang(Shanghai Jiao Tong University), Kun Sun(Shanghai Jiao Tong University), Yushu Qiu(Shanghai Jiao Tong University), Chunjiang Pi, Minfang Feng, Yu Guo(Nankai University), Minmin Lu(Army Medical University), Shū Shěn(Chinese Academy of Sciences), Jia Wu, Mengshi Huang, Dakun Huang(Zhejiang Center for Disease Control and Prevention), Wanju Zhang(Shanghai Public Health Clinical Center), He Zhou, Qiuling Xie(Shanghai Jiao Tong University), Liang Schweizer(HiFiBiO Therapeutics (United States)), Cheryl H. Cui(Harvard–MIT Division of Health Sciences and Technology), Bingqing Shen, Yuan Wang(Nankai University), Wei Wang(Central South University of Forestry and Technology), Da Chen(Nankai University), Shanshan Wang(Ningbo University), Mingjie Chen, Hongkai Zhang(Nanchang University), Ouyang Li(Fudan University), Xiaochen Han(Tangshan People's Hospital), Xinxin Zeng(Shanghai Jiao Tong University), Xingdong Zhou(Nankai University), Yujie Tian(Nankai University), Jeff He, Yun-Yueh Lu, Fēi Dèng(Hubei University of Medicine), Shuming Pan(XinHua Hospital), Heyu Huang(Henan University of Engineering), Qingqing Jing
Cited by 1
Related Papers
TTD: <i>Therapeutic Target Database</i> describing target druggability information
|Nucleic Acids Research|2023|578
Taxonomy of the order Bunyavirales: update 2019
|Archives of Virology|2019|405
SARS-CoV-2 cell tropism and multiorgan infection
|Cell Discovery|2021|241
Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Patients with Sepsis: A Prospective Observational Study
|Mediators of Inflammation|2016|228